Press Releases Heart Test Laboratories, Inc.

Equities

HSCS

US42254E1047

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
6.97 ^USD	-38.37%		-22.47%	-59.24%

Apr. 24	HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG	CI
Mar. 26	HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG	Apr. 24	GL
HeartSciences to Present at the LD Micro Invitational XIV Conference	Apr. 02	GL
HeartSciences to Present at the LD Micro Invitational XIV Conference	Apr. 02	AQ
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients	Mar. 26	GL
HeartSciences Reports Third Quarter Fiscal 2024 Financial Results	Mar. 14	GL
HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes	Mar. 12	GL
HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology	Mar. 06	GL
HeartSciences Adds Key Advisor to its Scientific Advisory Board	Feb. 26	GL
HeartSciences Adds Key Advisor to its Scientific Advisory Board	Feb. 26	AQ
HeartSciences Expands its Scientific Advisory Board	Feb. 12	GL
HeartSciences Appoints New Scientific Advisory Board Member	Feb. 01	GL
HeartSciences Appoints New Scientific Advisory Board Member	Feb. 01	AQ
HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting	Jan. 18	GL
HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting	Jan. 18	AQ
HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting	Jan. 03	GL
HeartSciences Reports Second Quarter Fiscal 2024 Financial Results	Dec. 14	GL
HeartSciences Receives FDA Confirmation for 510(k) Clearance Pathway	Dec. 05	GL
HeartSciences Announces Closing of License Agreements with the Icahn School of Medicine at Mount Sinai to Develop and Commercialize AI Cardiovascular Algorithms	Nov. 20	GL
HeartSciences Announces Closing of License Agreements with the Icahn School of Medicine at Mount Sinai to Develop and Commercialize AI Cardiovascular Algorithms	Nov. 20	AQ
HeartSciences’ MyoVista® wavECGTM Selected for Heart Screening of Irish Garda National Police Officers	Nov. 13	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Heart Test Laboratories, Inc.

Equities

HSCS

US42254E1047

Press Releases

Filters